203 related articles for article (PubMed ID: 17962027)
1. Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs.
Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Jan; 16(2):922-40. PubMed ID: 17962027
[TBL] [Abstract][Full Text] [Related]
2. Antitumor studies. part 3: design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins.
Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2007 Oct; 15(19):6336-52. PubMed ID: 17644399
[TBL] [Abstract][Full Text] [Related]
3. Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins.
Shrestha AR; Ali HI; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Oct; 16(20):9161-70. PubMed ID: 18819815
[TBL] [Abstract][Full Text] [Related]
4. Antitumor studies. Part 1: design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents.
Ali HI; Tomita K; Akaho E; Kambara H; Miura S; Hayakawa H; Ashida N; Kawashima Y; Yamagishi T; Ikeya H; Yoneda F; Nagamatsu T
Bioorg Med Chem; 2007 Jan; 15(1):242-56. PubMed ID: 17049252
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin-cholestane hybrid compounds.
Shrestha AR; Shindo T; Ashida N; Nagamatsu T
Bioorg Med Chem; 2008 Sep; 16(18):8685-96. PubMed ID: 18723355
[TBL] [Abstract][Full Text] [Related]
6. Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.
Ali HI; Tomita K; Akaho E; Kunishima M; Kawashima Y; Yamagishi T; Ikeya H; Nagamatsu T
Eur J Med Chem; 2008 Jul; 43(7):1376-89. PubMed ID: 18055068
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs.
Mahmoud S; Samaha D; Mohamed MS; Abou Taleb NA; Elsawy MA; Nagamatsu T; Ali HI
Molecules; 2020 May; 25(11):. PubMed ID: 32481639
[TBL] [Abstract][Full Text] [Related]
8. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives.
Jung JC; Lee JH; Oh S; Lee JG; Park OS
Bioorg Med Chem Lett; 2004 Nov; 14(22):5527-31. PubMed ID: 15482917
[TBL] [Abstract][Full Text] [Related]
11. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
13. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives.
Li J; Tan JZ; Chen LL; Zhang J; Shen X; Mei CL; Fu LL; Lin LP; Ding J; Xiong B; Xiong XS; Liu H; Luo XM; Jiang HL
Acta Pharmacol Sin; 2006 Sep; 27(9):1259-71. PubMed ID: 16923349
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activities of 1-benzylidine substituted beta-carboline derivatives.
Cao R; Yi W; Wu Q; Guan X; Feng M; Ma C; Chen Z; Song H; Peng W
Bioorg Med Chem Lett; 2008 Dec; 18(24):6558-61. PubMed ID: 18952426
[TBL] [Abstract][Full Text] [Related]
19. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.
Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH
J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]